Read + Share
Amedeo Smart
Independent Medical Education
Ebi H. Drug-Tolerant Persister Cells After EGFR Tyrosine Kinase Inhibitor Treatment: Their Origin and the Influences From the Tumor Microenvironment. J Thorac Oncol 2023;18:399-401.PMID: 36990572
Email
LinkedIn
Facebook
Twitter
Privacy Policy